Daptomycin: Another Novel Agent for Treating Infections Due to Drug‐Resistant Gram‐Positive Pathogens
Top Cited Papers
Open Access
- 1 April 2004
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 38 (7) , 994-1000
- https://doi.org/10.1086/383472
Abstract
Daptomycin is a novel cyclic lipopeptide antibiotic that provides rapid bactericidal activity against gram-positive pathogens in vitro, including metKeywords
This publication has 17 references indexed in Scilit:
- In Vitro Bactericidal Activities of Daptomycin against Staphylococcus aureus and Enterococcus faecalis Are Not Mediated by Inhibition of Lipoteichoic Acid BiosynthesisAntimicrobial Agents and Chemotherapy, 2003
- Baseline Study To Determine In Vitro Activities of Daptomycin against Gram-Positive Pathogens Isolated in the United States in 2000-2001Antimicrobial Agents and Chemotherapy, 2003
- Novel antibacterial agents for the treatment of serious Gram-positive infectionsExpert Opinion on Investigational Drugs, 2003
- Quinupristin‐Dalfopristin and Linezolid: Evidence and OpinionClinical Infectious Diseases, 2003
- Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000-2001.Journal of Antimicrobial Chemotherapy, 2003
- Novel agents for the treatment of resistant Gram-positive infectionsExpert Opinion on Investigational Drugs, 2003
- Activity of daptomycin against Gram-positive pathogens: a comparison with other agents and the determination of a tentative breakpointJournal of Antimicrobial Chemotherapy, 2001
- Development of daptomycin for Gram-positive infectionsJournal of Antimicrobial Chemotherapy, 2000
- Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro testsDiagnostic Microbiology and Infectious Disease, 2000
- Daptomycin: a novel agent for Gram-positive infectionsExpert Opinion on Investigational Drugs, 1999